John T. Treace insider trades: Treace Medical Concepts (TMCI) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
24 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | TMCI | ↑ Buy | 55,944 | $4.41 | $247K | Direct | Aug 24, 2026 (0d) |
| Jun 11, 2026 | TMCI | ↑ Buy | 24,606 | $4.03 | $99K | Direct | Jun 12, 2026 (1d) |
| Jun 11, 2026 | TMCI | ↑ Buy | 52,317 | $4.03 | $211K | Direct | Jun 11, 2026 (0d) |
| May 28, 2026 | TMCI | ↑ Buy | 115,520 | $2.95 | $341K | Direct | May 28, 2026 (0d) |
| May 14, 2026 | TMCI | ↑ Buy | 153,763 | $2.44 | $376K | Direct | May 14, 2026 (0d) |
| Mar 4, 2025 | TMCI | ↑ Buy | 60,000 | $8.73 | $524K | Direct | Mar 4, 2025 (0d) |
| Sep 16, 2024 | TMCI | ↑ Buy | 50,000 | $5.31 | $266K | Direct | Sep 17, 2024 (1d) |
| Aug 14, 2024 | TMCI | ↑ Buy | 85,000 | $6.00 | $510K | Direct | Aug 15, 2024 (1d) |
| Jun 11, 2024 | TMCI | ↑ Buy | 45,000 | $5.88 | $265K | Direct | Jun 11, 2024 (0d) |
| May 17, 2024 | TMCI | ↑ Buy | 100,000 | $5.56 | $556K | Direct | May 20, 2024 (3d) |
| May 14, 2024 | TMCI | ↑ Buy | 150,000 | $5.12 | $768K | Direct | May 14, 2024 (0d) |
| May 13, 2024 | TMCI | ↑ Buy | 300,000 | $4.57 | $1.4M | Direct | May 13, 2024 (0d) |
| Mar 9, 2023 | TMCI | ↓ Sell | 2,075 | $24.41 | $51K | Direct | Mar 10, 2023 (1d) |
| Nov 21, 2022 | TMCI | ↑ Buy | 15,000 | $21.83 | $327K | Direct | Nov 21, 2022 (0d) |
| Nov 17, 2022 | TMCI | ↑ Buy | 10,000 | $21.67 | $217K | Direct | Nov 17, 2022 (0d) |
| Sep 1, 2022 | TMCI | ↑ Buy | 10,000 | $19.80 | $198K | Direct | Sep 1, 2022 (0d) |
| Aug 26, 2022 | TMCI | ↑ Buy | 21,491 | $20.95 | $450K | Direct | Aug 29, 2022 (3d) |
| Aug 24, 2022 | TMCI | ↑ Buy | 28,509 | $18.72 | $534K | Direct | Aug 24, 2022 (0d) |
| Dec 29, 2021 | TMCI | ↓ Sell | 22,835 | $17.00 | $388K | Direct | Dec 30, 2021 (1d) |
| Dec 27, 2021 | TMCI | ↓ Sell | 81,670 | $16.72 | $1.4M | Direct | Dec 27, 2021 (0d) |
| Dec 21, 2021 | TMCI | ↓ Sell | 60,495 | $15.98 | $966K | Direct | Dec 22, 2021 (1d) |
| Nov 24, 2021 | TMCI | ↓ Sell | 165,000 | $17.86 | $2.9M | Direct | Nov 24, 2021 (0d) |
| Oct 22, 2021 | TMCI | ↓ Sell | 165,000 | $21.55 | $3.6M | Direct | Oct 22, 2021 (0d) |
| Apr 27, 2021 | TMCI | ↓ Sell | 5,253,805 | $17.00 | $89.3M | Direct | Apr 29, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About John T. Treace's insider trades
John T. Treace is Chief Executive Officer at Treace Medical Concepts (TMCI). Since Apr 27, 2021, John has reported 17 open-market purchases worth $7.3M and 7 sales worth $98.6M on SEC Form 4. In the last 12 months: 5 buys ($1.3M).
Their filings also include shares withheld for taxes (6 filings), grants and awards (6 filings), conversions (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TMCI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.